Most Accurate CGM in 2026: MARD Scores Compared (Every Sensor)

Meta description: Every CGM ranked by MARD accuracy in 2026 — Libre 3, Dexcom G7, Lingo, Stelo — what MARD means, why small differences barely matter, and which to buy.

Updated July 2026

The most accurate CGM in 2026 is the Abbott FreeStyle Libre 3, with a published MARD of approximately 7.8%, followed closely by the Dexcom G7 at about 8.2% — both prescription sensors. Among over-the-counter options, Abbott Lingo leads at ~9.3% with Dexcom Stelo close behind at ~10%. Here's the honest part most accuracy roundups skip: for non-insulin users, every sensor on this list is accurate enough, and the 2-point MARD spread should almost never decide your purchase.

What MARD Actually Means

MARD — Mean Absolute Relative Difference — is the standard accuracy metric for CGMs: the average percentage gap between the sensor's readings and simultaneous laboratory blood glucose measurements. A 9% MARD means readings land, on average, within 9% of true blood glucose. Lower is better, and anything under ~10% is considered clinically strong (the threshold historically used for insulin-dosing decisions).

Two caveats before comparing numbers:

1. MARD figures come from each manufacturer's own clearance studies under controlled conditions. Real-world accuracy varies with hydration, sensor placement, day of wear (day 1 reads worse than day 5), and glucose rate-of-change.
2. All CGMs read interstitial fluid, not blood — a 5–15 minute lag behind blood glucose that no MARD figure captures. During rapid rises after meals, every sensor smooths and delays the true peak.

How MARD Is Measured — and Why Cross-Brand Comparisons Are Fuzzy

The number comes from clinical accuracy studies: participants wear the sensor while researchers draw venous blood at intervals and run it through a laboratory reference analyzer. Every paired sensor-vs-lab reading produces an error percentage; MARD is the average of all of them.

The catch is that each manufacturer runs its own study, with its own protocol — different participant mixes, different proportions of readings taken during rapid glucose swings (where all sensors perform worst), different wear-day sampling. A sensor tested against a gentler protocol can post a flatter number without being better hardware. This is why a 0.5–1 point MARD gap between two sensors from two different studies is closer to methodological noise than a real ranking, and why regulators evaluate accuracy on much richer data than the single headline figure.

MARD is also an average, not a guarantee. A sensor averaging 9% error still produces individual readings well outside that band, and it says nothing about where errors cluster. Clinical evaluations use additional tools — per-range accuracy breakdowns and error-grid analyses that classify whether a given error could actually cause a harmful decision — precisely because one blended number hides that detail. For consumer purposes, the takeaway is simple: MARD is a rough quality tier, not a precision score. Every sensor below sits in the same top tier.

2026 MARD Rankings

Note the pattern: the consumer OTC sensors are slightly detuned versions of the same platforms as the clinical leaders. Buying a coaching program like Nutrisense (Libre-based) or Signos (Dexcom-based) gets you the underlying clinical sensor with a software layer on top — the accuracy comes from the hardware, not the subscription.

Why the Differences Barely Matter for Wellness Use

At a true blood glucose of 120 mg/dL, a 7.8%-MARD sensor averages within ~9 mg/dL and a 10%-MARD sensor within ~12 mg/dL. For the questions non-insulin users actually ask — did that meal spike me? did the walk help? is my baseline drifting down? — a 3 mg/dL average difference changes nothing. Trends, spike detection, and time-in-range are robust across every sensor listed.

Where accuracy genuinely matters is insulin dosing and hypoglycemia detection — prescription territory with alarms, which no OTC sensor provides by design.

There's a broader framing worth keeping in mind: for people without diabetes, a CGM is an educational tool, not a diagnostic instrument. It's excellent at showing you relative patterns — which meals spike you, whether a post-meal walk helps, how bad sleep moves your baseline — and glucose responses are individual enough that this personalization is the whole value. What no wellness CGM can do is diagnose prediabetes or diabetes; that requires physician-ordered labs (HbA1c, fasting glucose). If your sensor consistently shows readings that concern you, that's a reason to see a doctor, not to buy a more accurate sensor.

So choose on the factors that actually differ: price, sensor life, integrations, and app — which is exactly how we rank the best CGMs for non-diabetics, and why our overall pick is Stelo (integrations, 15-day wear) despite Lingo's nominally better MARD (head-to-head here).

What Actually Degrades Real-World Accuracy

The gap between your sensor's published MARD and what you experience on your arm comes from a handful of predictable factors:

• Day of wear. The first 12–24 hours after insertion are the noisiest on every platform, as tissue around the filament settles. Accuracy typically improves through mid-wear, and some users see drift again in the final days.
• Rate of change. All sensors are least accurate when glucose is moving fast — the interstitial lag means a sensor can read 20+ mg/dL behind blood during a steep post-meal climb. Stable periods are where readings are most trustworthy.
• Compression. Pressure on the sensor (classically, sleeping on the sensor arm) squeezes interstitial fluid away from the filament and produces dramatic false lows. A single overnight "low" that recovers when you change position is almost always this artifact.
• Hydration. Dehydration degrades interstitial readings across platforms.
• Substance interference. Certain common substances can bias specific sensor chemistries — high-dose vitamin C supplementation is a documented interferent on Abbott's platform, for example. Check the labeling for the sensor you buy if you take large supplement doses regularly.
• Placement. Stick to the approved site (back of the upper arm for all sensors here). Off-label placements void the accuracy data entirely.

Getting the Most Accurate Readings From Any Sensor

• Trust days 2–14 more than day 1 — sensors settle after the first 12–24 hours
• Ignore single overnight lows if you sleep on the sensor arm (compression lows are pressure artifacts)
• Judge trends, not single numbers — the curve's shape carries the insight; individual readings carry the noise
• Stay hydrated — dehydration degrades interstitial readings on every platform
• Confirm oddities with a fingerstick if a reading contradicts how you feel

Bottom Line

The 2026 accuracy hierarchy is real but narrow: Abbott's Libre 3 leads on paper, Dexcom's G7 sits just behind, and their OTC siblings — Lingo and Stelo — trail by a point or two of MARD that you will never notice in wellness use. Every sensor in this article clears the bar for the job non-diabetics are hiring it to do: comparing meals, catching spikes, and tracking trends. Buy on price, sensor life, app philosophy, and integrations; treat the MARD column as a tiebreaker at most. And if the reason you're shopping for the "most accurate" sensor is worry about a real medical condition, the most accurate tool available is a lab draw ordered by your physician — start there.

Frequently Asked Questions

What is the most accurate CGM in 2026?

The Abbott FreeStyle Libre 3, with a published MARD of about 7.8%, is the most accurate CGM in 2026, with the Dexcom G7 close behind at ~8.2% — both prescription sensors. Among over-the-counter CGMs, Abbott Lingo leads at ~9.3%, followed by Dexcom Stelo at ~10%. All four are accurate enough for non-insulin wellness use.

What is a good MARD score for a CGM?

Under 10% is considered clinically strong — historically the bar for insulin-dosing decisions. Every major 2026 sensor clears or nearly clears it: Libre 3 (7.8%), G7 (8.2%), Lingo (9.3%), Stelo (10%). Sensors above ~12–14% MARD, common in older generations, are where accuracy concerns become practical.

Is Dexcom or Libre more accurate?

By published MARD, Abbott's Libre 3 (7.8%) edges Dexcom's G7 (8.2%), and the same ordering holds for their OTC versions — Lingo (9.3%) vs Stelo (10%). In practice the gap is within study-methodology noise; head-to-head wear shows the platforms tracking each other closely. Choose on features and price, not this margin.

Why does my CGM not match my fingerstick meter?

Three reasons, all normal: CGMs read interstitial fluid, which lags blood glucose by 5–15 minutes; both devices carry their own error margins (a fingerstick meter is allowed ±15% itself); and pressure on the sensor (like sleeping on it) causes false lows. Discrepancies of 10–20 mg/dL during stable periods — larger during rapid changes — are expected, not a defect.

Are OTC CGMs less accurate than prescription ones?

Slightly, by design and by number — Lingo (9.3%) and Stelo (10%) versus their prescription siblings at ~7.8–8.2%. The difference is irrelevant for meal comparison, spike detection, and trend tracking. What OTC sensors genuinely lack is urgent-low alarms and insulin-dosing clearance, which is why insulin users still need prescription devices.

Is a CGM accurate enough to diagnose diabetes or prediabetes?

No — and this isn't about MARD. Wellness CGMs aren't cleared as diagnostic devices, and diagnosis is defined by standardized lab tests: HbA1c, fasting plasma glucose, or an oral glucose tolerance test ordered by a physician. A CGM showing consistently elevated readings is a good reason to get those labs; it is not itself a diagnosis.

Does MARD change over the life of a sensor?

Effectively yes — published MARD is an average across the full wear period, but real-world error isn't flat. Sensors read worst in the first 12–24 hours while tissue settles, best through mid-wear, and sometimes drift near end of life. That's why day-one data deserves skepticism on every platform, regardless of the headline number.

Can supplements or medications affect CGM accuracy?

Some can. High-dose vitamin C is a documented interferent for Abbott's sensing chemistry, and certain medications have historically biased other platforms. If you take large supplement doses or regular medication, read the interference section of your sensor's labeling — and treat readings that contradict how you feel as a prompt for a fingerstick check, not gospel.

Is a fingerstick meter more accurate than a CGM?

At a single moment, usually yes — a fingerstick measures capillary blood directly with no interstitial lag, though meters themselves are allowed roughly ±15% error. What CGMs add isn't point accuracy but continuity: hundreds of readings a day revealing trends, spikes, and overnight patterns no amount of fingersticking captures. They're complementary tools, not competitors.

Disclaimer: This article contains affiliate links. We may earn a commission if you purchase through our links, at no additional cost to you. This content is not medical advice — consult your clinician before making decisions about glucose monitoring or diabetes care.